Posts Tagged: prostate cancer


NIH Director Collins Stands Up to the March in Mob

The problem with this theory is that the Bayh-Dole Act does not provide agencies the authority to regulate product prices. The law allows universities and contractors to …
By Joseph Allen
4 years ago 0

Blue Ribbon Panel of Advisors Announced for Biden Cancer Moonshot Initiative

Earlier this week the National Cancer Institute (NCI), which is part of the National Institutes of Health, announced a Blue Ribbon Panel of scientific experts, cancer leaders, …
By Gene Quinn
5 years ago 5

Bolder initiatives needed to take next steps in fight against cancer

February 4 is World Cancer Day... There has been steady progress made in the history of treating cancers of many types since the administration of former U.S …
By Steve Brachmann
5 years ago 4

Federal funding for a cancer moonshot is not a terrible idea

To hear Ars Technica say it is ''a terrible idea'' to devote increased funding in order to eradicate cancer is astonishing on many levels. As part of …

Innovation at Historically Black Colleges and Universities

The first patent received by an HBCU was on April 11, 1978, assigned to Shaw University of Raleigh, NC. Between 1969 and 2012, HBCUs received 100 utility patents from the U.S. …

FTC Upholds Decision on Deceptive Advertising of Pomegranate Products

The Commission issued a Final Order that bars the POM marketers from making any claim that a food, drug, or dietary supplement is “effective in the diagnosis, …

Patent Granted on Long-Acting Drug for Multiple Sclerosis

The conjugates covered by this patent could enable less frequent and better tolerated dosing of one of the most widely used treatments worldwide for relapsing-remitting multiple sclerosis, …
By Gene Quinn
8 years ago 0

US Oncologists Report Crucial Cancer Drug Shortages

The mantra of the anti-patent community is nearly in unison on the issue of patented drugs. Of course, everyone wants drugs to be developed, but no one …
By Gene Quinn
8 years ago 0

Poniard Pharmaceuticals: Positive Phase 2 News and Patent Portfolio Could Make it a Good Buy

Now here is what really caught my attention about PARD, on November 13, 2009 the stock was trading at $7.58, and on Monday, November 16, 2009 it dropped like a rock to $1.83, …
By Gene Quinn
11 years ago 6